SCHEMBL8811486

SCHEMBL8811486

CCC(C)CCCC(C)CC[C]=O

nearest known ligand 0.39

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.39
BLM P54132 1/20 0.33
ACE2 Q9BYF1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8811527 1.00 LMNA (0.39) LMNABLMACE2
SCHEMBL269579 0.91
SCHEMBL5159997 0.91
SCHEMBL17143522 0.86
SCHEMBL17143810 0.86
SCHEMBL1410494 0.86
SCHEMBL4100336 0.84 LMNA (0.35) LMNAACE2
SCHEMBL17143627 0.84 LMNA (0.35) LMNAACE2
SCHEMBL1410630 0.84 LMNA (0.35) LMNAACE2
SCHEMBL1827120 0.84 LMNA (0.59) LMNABLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5691319-A ANTICARCINOGENIC AGENTS SANKYO COMPANY, LIMITED (JP) 1997-11-25 US disclosed
EP-0536936-B1 Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use SANKYO CO (JP) 1996-08-14 EP disclosed
EP-0583971-A1 Piperidine derivatives SANKYO COMPANY LIMITED (JP) 1994-02-23 EP disclosed
EP-0536936-A1 Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use Sankyo Company Limited (JP) 1993-04-14 EP disclosed